发明名称 Novel dosage form
摘要 There is provided inter alia apharmaceutical dosage form fororal administration comprising a sanglifehrin as active ingredient in which the sanglifehrin active ingredient is protected from acid degradation in the stomach environment following oral administration.
申请公布号 AU2012328142(A1) 申请公布日期 2014.05.15
申请号 AU20120328142 申请日期 2012.10.24
申请人 NEUROVIVE PHARMACEUTICAL AB 发明人 GREGORY, MATTHEW ALAN;MOSS, STEVEN JAMES
分类号 A61K9/00 主分类号 A61K9/00
代理机构 代理人
主权项
地址